Exploring anatomical brain heterogeneity in subjects with mild cognitive impairment

被引:0
作者
Pabon Ochoa, German A. [1 ]
Giraldo, Diana L. [2 ]
Romero, Eduardo [1 ]
机构
[1] Univ Nacl Colombia, CIM LAB, Bogota, Colombia
[2] Univ Antwerp, Imec Vis Lab, Antwerp, Belgium
来源
2023 19TH INTERNATIONAL SYMPOSIUM ON MEDICAL INFORMATION PROCESSING AND ANALYSIS, SIPAIM | 2023年
基金
加拿大健康研究院; 美国国家卫生研究院;
关键词
Mild Cognitive Impairment; Alzheimer's Disease; Quantitative characterization; Voxel-based Morphometry; Computational neuroscience; VOXEL-BASED MORPHOMETRY; PROFILE;
D O I
10.1109/SIPAIM56729.2023.10373453
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
The wide range of clinical manifestations in Mild Cognitive Impairment (MCI) poses a significant challenge. The inherent heterogeneity within MCI emphasizes the importance of a comprehensive characterization of individuals diagnosed with this condition. We identified and characterized MCI subgroups with distinct neuropsychological profiles within the Alzheimer's Disease Neuroimaging Initiative. A total of 194 individuals diagnosed with MCI were partitioned into 7 subgroups using a data-driven clustering approach that incorporated followup information. Voxel-based morphometry was then utilized to investigate patterns of gray matter atrophy in each of these subgroups, comparing them against 108 cognitively normal individuals. The analysis disclosed specific brain regions with significant differences. A remarkable relationship between cognitive impairment and the extent of brain atrophy was observed. Increasing cognitive and behavioral abnormalities corresponded to more extensive gray matter atrophy patterns. This study enhances the understanding of neurodegenerative patterns in mild cognitive impairment, providing valuable perspectives for improved characterization and potential interventions in the prodromal stage of Alzheimer's Disease.
引用
收藏
页数:5
相关论文
共 20 条
  • [1] Voxel-based morphometry - The methods
    Ashburner, J
    Friston, KJ
    [J]. NEUROIMAGE, 2000, 11 (06) : 805 - 821
  • [2] Why voxel-based morphometry should be used
    Ashburner, J
    Friston, KJ
    [J]. NEUROIMAGE, 2001, 14 (06) : 1238 - 1243
  • [3] Mild cognitive impairment: prevalence, prognosis, aetiology, and treatment
    DeCarli, C
    [J]. LANCET NEUROLOGY, 2003, 2 (01) : 15 - 21
  • [4] Heterogeneity in mild cognitive impairment: Differences in neuropsychological profile and associated white matter lesion pathology
    Delano-Wood, Lisa
    Bondi, Mark W.
    Sacco, Joshua
    Abeles, Norm
    Jak, Amy J.
    Libon, David J.
    Bozoki, Andrea
    [J]. JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY, 2009, 15 (06) : 906 - 914
  • [5] Heterogeneous cortical atrophy patterns in MCI not captured by conventional diagnostic criteria
    Edmonds, Emily C.
    Eppig, Joel
    Bondi, Mark W.
    Leyden, Kelly M.
    Goodwin, Bailey
    Delano-Wood, Lisa
    McDonald, Carrie R.
    [J]. NEUROLOGY, 2016, 87 (20) : 2108 - 2116
  • [6] Susceptibility of the conventional criteria for mild cognitive impairment to false-positive diagnostic errors
    Edmonds, Emily C.
    Delano-Wood, Lisa
    Clark, Lindsay R.
    Jak, Amy J.
    Nation, Daniel A.
    McDonald, Carrie R.
    Libon, David J.
    Au, Rhoda
    Galasko, Douglas
    Salmon, David P.
    Bondi, Mark W.
    [J]. ALZHEIMERS & DEMENTIA, 2015, 11 (04) : 415 - 424
  • [7] Statistically Derived Subtypes and Associations with Cerebrospinal Fluid and Genetic Biomarkers in Mild Cognitive Impairment: A Latent Profile Analysis
    Eppig, Joel S.
    Edmonds, Emily C.
    Campbell, Laura
    Sanderson-Cimino, Mark
    Delano-Wood, Lisa
    Bondi, Mark W.
    [J]. JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY, 2017, 23 (07) : 564 - 576
  • [8] Quantification of cognitive impairment to characterize heterogeneity of patients at risk of developing Alzheimer's disease dementia
    Giraldo, Diana L.
    Sijbers, Jan
    Romero, Eduardo
    [J]. ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING, 2021, 13 (01)
  • [9] CSF biomarkers of Alzheimer's disease concord with amyloid-β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts
    Hansson, Oskar
    Seibyl, John
    Stomrud, Erik
    Zetterberg, Henrik
    Trojanowski, John Q.
    Bittner, Tobias
    Lifke, Valeria
    Corradini, Veronika
    Eichenlaub, Udo
    Batrla, Richard
    Buck, Katharina
    Zink, Katharina
    Rabe, Christina
    Blennow, Kaj
    Shaw, Leslie M.
    [J]. ALZHEIMERS & DEMENTIA, 2018, 14 (11) : 1470 - 1481
  • [10] Should mild cognitive impairment be subtyped?
    Hughes, Tiffany F.
    Snitz, Beth E.
    Ganguli, Mary
    [J]. CURRENT OPINION IN PSYCHIATRY, 2011, 24 (03) : 237 - 242